Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

VVerrica Pharmaceuticals Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
V

Verrica Pharmaceuticals Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $5.86M. Net result −$13.15M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $5.86M. Running result $5.86M. License And Collaboration Revenue: $769K. Product: $5.09M.
  • Cost of revenue: $0. Running result $5.86M.
  • Gross profit: $5.86M. Running result $5.86M.
  • Operating costs: −$18.96M. Running result −$13.1M.
  • Operating income: −$13.1M. Running result −$13.1M.
  • Other expense: −$56K. Running result −$13.15M.
  • Pre-tax loss: −$13.15M. Running result −$13.15M.
  • Income tax benefit: $0. Running result −$13.15M.
  • Net loss: −$13.15M. Running result −$13.15M.